A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

May 2024 Medicare Drug List Updates: Fifty-two (52) medications added to the 2024 Medicare Part D Drug plan formularies.

Category: Monthly Formulary changes
Published: Jun, 02 2024 10:06:42


The May 2024 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The May formulary updates include the addition of 99 new National Drug Codes (NDCs), representing 52 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).


Highlights of the May 2024 Formulary updates include ten (10) newly-introduced brand-name drugs

The May drug data updates include fifteen (15) new brand-name drugs, ten (10) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • CABTREO®,
  • IXCHIQ®,
  • JOENJA®,
  • MOTPOLY XR®,
  • NEXICLON XR®,
  • OZOBAX DS®,
  • ProctoFoam HC®,
  • QDOLO®,
  • RIVFLOZA®, and
  • VEVYE®.

The May 2024 Formulary updates include ten (10) newly-added generic drugs

The May Medicare Part D drug data also includes thirty-seven (37) new generic medications, ten (10) of which are newly-introduced generic drugs.  These new generic drugs include:
  • AMETHIA [Simpesse®],
  • BISOPROLOL FUMARATE [Zebeta®],
  • BROMFENAC SOD [BromSite®],
  • CETIRIZINE HCL [Zyrtec Syrup®],
  • CYCLOSERINE [Seromycin®],
  • DEFLAZACORT [Emflaza®],
  • HEATHER [Sharobel 28-Day®],
  • LOTEPREDNOL ETABONATE [Alrex®],
  • MIFEPRISTONE [Korlym®], and
  • TRIENTINE HCL®].
Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

You can read more about the new generics in our article: May 2024 Drug List Updates: Thirty-seven (37) new generic drugs added to many Medicare Part D plan formularies.


Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. In most cases, your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155


Summary of May 2024 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 99 new May 2024 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 2
New Delivery Form and Strength 2
New Drug 30
New Drug and Strength 22
New Drug, Delivery Form and Strength 1
New Drug, Manufacturer and Strength 4
New Manufacturer 2
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 21
New Manufacturer, Delivery Form and Strength 6
New Strength 8
Grand Total 99

The following chart details the 99 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.


NDC Drug Name Number of
PDP Formularies*
Number of
MAPD Formularies*
Notes
65219061299 ADALIMUMAB-AACF(CF) PEN 40 MG PEN IJ KIT [Idacio] 2 27 New Drug
00480927706 ALYQ 20 MG TABLET [Cialis] 28 252 New Drug
51862004701 AMETHIA 0.15-0.03-0.01 MG TABLET TBDSPK 3MO [Simpesse] 27 217 New Drug
66794020815 AMPICILLIN-SULBACTAM 15 GM VIAL [Unasyn] 38 339 New Manufacturer and Strength
68382000301 AZATHIOPRINE 50 MG TABLET [Imuran] 54 369 New Drug
00168026850 BETAMETHASONE DP AUG 0.05% OINTMENT [Diprolene] 54 364 New Manufacturer and Delivery Form
70954045620 BISOPROLOL FUMARATE 10 MG TABLET [Zebeta] 54 368 New Drug and Strength
70954045520 BISOPROLOL FUMARATE 5 MG TABLET [Zebeta] 54 368 New Drug and Strength
42799092001 BISOPROLOL-HCTZ 2.5-6.25 MG TABLET [Ziac] 52 368 New Strength
42799092101 BISOPROLOL-HCTZ 5-6.25 MG TABLET [Ziac] 52 368 New Strength
70069023101 BRIMONIDINE 0.2% EYE DROPS [Alphagan] 54 369 New Drug
49708075541 BROMFENAC SOD 0.075% EYE DROPS [BromSite] 2 85 New Drug
69238120302 BUPRENORPHINE 10 MCG/HR PATCH [Butrans] 15 216 New Drug and Strength
69238120402 BUPRENORPHINE 15 MCG/HR PATCH [Butrans] 15 216 New Drug and Strength
69238120502 BUPRENORPHINE 20 MCG/HR PATCH [Butrans] 15 216 New Drug and Strength
00054017613 BUPRENORPHINE 2 MG TABLET SUBLIGUAL [Subutex] 54 369 New Drug, Manufacturer and Strength
00187000625 CABTREO 1.2%-0.15%-3.15% GEL 0 1 New Drug
65862070020 CEFUROXIME AXETIL 500 MG TABLET [Ceftin] 54 369 New Manufacturer and Strength
00121087416 CETIRIZINE HCL 1 MG/ML SOLUTION [Zyrtec Syrup] 28 216 New Drug
68462029735 CICLOPIROX 0.77% CREAM (G) [Loprox] 53 368 New Manufacturer, Delivery Form and Strength
61314065605 CIPROFLOXACIN 0.3% EYE DROPS [Ciloxan] 54 369 New Drug
00009766705 CLEOCIN 100 MG VAGINAL OVULE SUPP.VAG 2 54 New Drug
52817037530 CLONIDINE HCL ER 0.17 MG TABLET 24H 0 4 New Manufacturer and Strength
13107032001 CLORAZEPATE 7.5 MG TABLET [Tranxene T-Tab] 54 368 New Drug
00574010770 CLOTRIMAZOLE 10 MG TROCHE [Mycelex Troche] 54 369 New Drug
70010000201 COLCHICINE 0.6 MG TABLET [Colcrys] 53 367 New Drug
43598023531 CYCLOSERINE 250 MG CAPSULE [Seromycin] 17 91 New Drug
60505434906 DABIGATRAN ETEXILATE 110 MG CAPSULE [Pradaxa] 32 170 New Drug, Manufacturer and Strength
31722062260 DABIGATRAN ETEXILATE 150 MG CAPSULE [Pradaxa] 44 269 New Drug, Manufacturer and Strength
31722062160 DABIGATRAN ETEXILATE 75 MG CAPSULE [Pradaxa] 44 269 New Drug, Manufacturer and Strength
67877044460 DALFAMPRIDINE ER 10 MG TABLET 12H [Ampyra] 54 369 New Drug
83649033001 DARAPRIM 25 MG TABLET 0 5 New Drug
59651060030 DEFLAZACORT 18 MG TABLET [Emflaza] 0 15 New Drug and Strength
59651060130 DEFLAZACORT 30 MG TABLET [Emflaza] 0 15 New Drug and Strength
59651060230 DEFLAZACORT 36 MG TABLET [Emflaza] 0 15 New Drug and Strength
59651059901 DEFLAZACORT 6 MG TABLET [Emflaza] 0 15 New Drug and Strength
70436001304 DESVENLAFAXINE SUCCNT ER 100MG TABLET 24H [Pristiq] 54 369 New Manufacturer and Strength
00781235201 DEXTROAMP-AMPHET ER 20 MG CAPSULE 24H [Adderall XR] 50 334 New Manufacturer and Strength
00781237101 DEXTROAMP-AMPHET ER 30 MG CAPSULE 24H [Adderall XR] 50 334 New Manufacturer and Strength
72205004060 DOFETILIDE 250 MCG CAPSULE [Tikosyn] 54 369 New Manufacturer and Strength
72205004160 DOFETILIDE 500 MCG CAPSULE [Tikosyn] 54 369 New Manufacturer and Strength
45802046653 ECONAZOLE NITRATE 1% CREAM (G) [Spectazole] 30 281 New Drug
00781324664 ENOXAPARIN 40 MG/0.4 ML SYRINGE [Lovenox] 54 369 New Manufacturer and Strength
60505619604 ERTAPENEM 1 GRAM VIAL [Invanz] 54 369 New Drug
66993000210 ESTRADIOL 0.01% CREAM/APPL [Estrace] 54 368 New Manufacturer, Delivery Form and Strength
00781714483 ESTRADIOL 0.05 MG PATCH (2/WK) PATCH TDSW [Vivelle-Dot] 48 350 New Manufacturer and Strength
69315028209 FENOFIBRIC ACID DR 135 MG CAPSULE [Trilipix] 27 289 New Manufacturer and Strength
45963055650 GABAPENTIN 300 MG CAPSULE [Neurontin] 54 369 New Manufacturer and Strength
67457040913 HALOPERIDOL DEC 100 MG/ML VIAL [Haldol Decanoate] 54 366 New Strength
68462030329 HEATHER 0.35 MG TABLET [Sharobel 28-Day] 41 221 New Drug
83457010301 CDV HYRIMOZ 40 MG/0.8 ML SYRINGE 0 5 New Manufacturer and Strength
83457010201 CDV HYRIMOZ PEN 40 MG/0.8 ML PEN INJECTOR 0 5 New Manufacturer and Strength
70954063710 INDOMETHACIN 25 MG/5 ML ORAL SUSPENSION [Indocin] 0 3 New Manufacturer, Delivery Form and Strength
24208039830 IPRATROPIUM 0.03% SPRAY [Atrovent] 54 369 New Manufacturer, Delivery Form and Strength
24208039915 IPRATROPIUM 0.06% SPRAY [Atrovent] 54 369 New Manufacturer, Delivery Form and Strength
42515000301 IXCHIQ Chikungunya 18 Years + Injectable 0.5mL Live SDV Ea 41 228 New Drug
71274017060 JOENJA 70 MG TABLET 2 45 New Drug
62332017460 LACOSAMIDE 200 MG TABLET [Vimpat] 54 369 New Manufacturer and Strength
72485065305 LOTEPREDNOL ETABONATE 0.2% DRP EYE DROPPER [Alrex] 9 88 New Drug and Strength
72485066505 LOTEPREDNOL ETABONATE 0.5% DRP EYE DROPPER [Lotemax] 14 181 New Drug and Strength
71717010611 METFORMIN HCL 1,000 MG TABLET [Glucophage] 54 369 New Manufacturer and Strength
13811070810 METHYLPHENIDATE ER 36 MG TABLET 24H [RELEXXII] 8 161 New Strength
13811070910 METHYLPHENIDATE ER 54 MG TABLET 24H [RELEXXII] 8 161 New Strength
00591439096 MIFEPRISTONE 300 MG TABLET [Korlym] 41 239 New Drug
73289006302 MOTPOLY XR 100 MG CAPSULE ER 24H 0 36 New Drug and Strength
73289006402 MOTPOLY XR 150 MG CAPSULE ER 24H 5 44 New Drug and Strength
73289006502 MOTPOLY XR 200 MG CAPSULE ER 24H 5 44 New Drug and Strength
71511070116 NAPROSYN 125 MG/5 ML ORAL SUSPENSION 0 1 New Drug
69784050001 EC-NAPROXEN DR 500 MG TABLET [EC-Naprosyn] 50 328 New Manufacturer and Strength
43547052603 NEBIVOLOL 10 MG TABLET [Bystolic] 40 352 New Drug and Strength
43547052403 NEBIVOLOL 2.5 MG TABLET [Bystolic] 40 352 New Drug and Strength
43547052703 NEBIVOLOL 20 MG TABLET [Bystolic] 40 352 New Drug and Strength
43547052503 NEBIVOLOL 5 MG TABLET [Bystolic] 40 352 New Drug and Strength
71511050330 NEXICLON XR 0.17 MG TABLET ER 24H 0 2 New Drug
69528030216 OZOBAX DS 10 MG/5 ML SOLUTION 0 5 New Drug
43975035003 PALIPERIDONE ER 3 MG TABLET 24H [Invega] 54 369 New Strength
43975035103 PALIPERIDONE ER 6 MG TABLET 24H [Invega] 54 369 New Strength
70010014701 POTASSIUM CL ER 8 MEQ CAPSULE ER [Micro-K Extencaps] 52 366 New Manufacturer and Strength
69097068105 PREGABALIN 100 MG CAPSULE [Lyrica] 54 369 New Manufacturer and Strength
00037682210 PROCTOFOAM-HC 1%-1% FOAM 0 24 New Drug
71511030116 QDOLO 5 MG/ML SOLUTION 0 6 New Drug
65862087011 RISEDRONATE SODIUM 150 MG TABLET [Actonel] 17 322 New Manufacturer and Strength
00169530708 RIVFLOZA 128 MG/0.8 ML SYRINGE 2 37 New Drug and Strength
00169530610 RIVFLOZA 160 MG/ML SYRINGE 2 35 New Drug and Strength
00169530801 RIVFLOZA 80 MG/0.5 ML VIAL 2 37 New Drug, Delivery Form and Strength
50242062342 ROZLYTREK 50 MG PELLET PACKET 41 246 New Delivery Form and Strength
27241012403 SILDENAFIL 20 MG TABLET [Revatio] 54 369 New Manufacturer, Delivery Form and Strength
70512084111 SODIUM CHLORIDE 0.9% IV SOLUTION 54 369 New Manufacturer
00143965901 TESTOSTERONE CYP 200 MG/ML VIAL [Virilon] 54 365 New Manufacturer
27241019130 TOLTERODINE TART ER 2 MG CAPSULE 24H [Detrol LA] 51 363 New Drug and Strength
27241019230 TOLTERODINE TART ER 4 MG CAPSULE 24H [Detrol LA] 51 363 New Drug and Strength
16571081205 TRIENTINE HCL 500 MG CAPSULE 11 87 New Drug
70010002703 TROSPIUM CHLORIDE ER 60 MG CAPSULE 24H [Sanctura XR] 8 213 New Drug
82667090002 VEVYE 0.1% EYE DROPS 0 4 New Drug
62332023430 VILAZODONE HCL 40 MG TABLET [VIIBRYD] 54 366 New Manufacturer and Strength
50242021555 XOLAIR 150 MG/ML AUTOINJECTOR 41 243 New Delivery Form
50242022755 XOLAIR 300 MG/2 ML AUTOINJECTOR 41 243 New Delivery Form and Strength
50242022701 XOLAIR 300 MG/2 ML SYRINGE 41 244 New Strength
50242021455 XOLAIR 75 MG/0.5 ML AUTOINJECTOR 41 243 New Delivery Form




If your brand-name drug is no longer covered by your Medicare Part D plan, you can use the 30-day notice period (if notice is provided) to:
Learn more in our article: How a mid-year formulary change can affect your Medicare Part D drug coverage.

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.







Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Compare Discounted Medication Prices
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.